{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:30:01Z","timestamp":1766982601278,"version":"3.48.0"},"reference-count":54,"publisher":"Informa UK Limited","issue":"23","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomarkers in Medicine"],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.1080\/17520363.2025.2595911","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:10:43Z","timestamp":1764652243000},"page":"1181-1187","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Contemporary perspective and practical application of glutamate dehydrogenase in nonclinical studies"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-5658","authenticated-orcid":false,"given":"Ravindra C.","family":"Kodihalli","sequence":"first","affiliation":[{"name":"Pfizer Inc","place":["Groton, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Ameri","sequence":"additional","affiliation":[{"name":"GSK","place":["Collegeville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S.","family":"Baker","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha C.","family":"Faber","sequence":"additional","affiliation":[{"name":"Takeda Development Center Americas, Inc","place":["San Diego, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-6346","authenticated-orcid":false,"given":"Armando R.","family":"Irizarry Rovira","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Groton, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah M.","family":"Norona","sequence":"additional","affiliation":[{"name":"Genentech Inc","place":["South San Francisco, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R","family":"Proctor","sequence":"additional","affiliation":[{"name":"GSK","place":["Collegeville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M. Caverly","family":"Rae","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb","place":["New Brunswick, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Regev","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie Z","family":"Sakatis","sequence":"additional","affiliation":[{"name":"GSK","place":["Stevenage, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic P.","family":"Williams","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Cambridge, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Zane","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc","place":["Foster City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payal","family":"Rana","sequence":"additional","affiliation":[{"name":"Pfizer Inc","place":["Groton, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0182-7"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805073381904"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801238-3.64265-4"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.4324\/9780203362563"},{"key":"e_1_3_8_7_1","volume-title":"Clinical biochemistry of domestic animals","author":"Kaneko JJ","year":"1989","unstructured":"Kaneko JJ. Clinical biochemistry of domestic animals. San Diego: Academic Press; 1989."},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0222"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2019.02.001"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229753"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29802"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300985815591076"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2024.143153"},{"key":"e_1_3_8_14_1","unstructured":"C-Path\u2019s PSTC D-RSC receive positive FDA response to plan for liver safety biomarker [Internet]. 2020. Available from: https:\/\/c-path.org\/c-paths-pstc-d-rsc-receive-positive-fda-response-to-plan-for-liver-safety-biomarker\/"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.920823"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59755"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4274(00)00218-6"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240562"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft009"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.11.021"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13202"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/01480540802390247"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1258\/002367702320162414"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.03.015"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(88)90356-7"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2016.1269131"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2017.05.001"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac539"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20548"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03001.x"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab003"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36858-6"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.4.1189"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfae143"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26714-w"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02989-4"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku142"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft278"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1210"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfaf003"},{"key":"e_1_3_8_41_1","unstructured":"FDA. DDTBMQ000050 qualification plan for glutamate dehydrogenase (GLDH) as a biomarker of drug induced liver injury in individuals with skeletal muscle degeneration. 2020. Available from: https:\/\/www.fda.gov\/media\/138320\/download"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1191\/096032700678815918"},{"key":"e_1_3_8_43_1","unstructured":"FDA. Guidance for industry: drug-induced liver injury - premarketing clinical evaluation. 2009. Available from: https:\/\/www.fda.gov\/media\/116737\/download"},{"key":"e_1_3_8_44_1","unstructured":"FDA. Qualification plan for glutamate dehydrogenase (GLDH) as a biomarker of drug induced liver injury in individuals with skeletal muscle degeneration. 2019. Available from: https:\/\/www.fda.gov\/media\/138319\/download"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft221"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/01926230252929945"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.40"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-42"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfae058"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfr266"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.054288"},{"key":"e_1_3_8_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01482"},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01667"},{"key":"e_1_3_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.09.004"},{"key":"e_1_3_8_55_1","unstructured":"FDA. FDA qualifies Glutamate Dehydrogenase (GLDH) biomarker to enhance liver safety monitoring in clinical trials. 2025. Available from: https:\/\/content.govdelivery.com\/accounts\/USFDA\/bulletins\/3fb44ee"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17520363.2025.2595911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:25:09Z","timestamp":1766982309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17520363.2025.2595911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,12,2]]}},"alternative-id":["10.1080\/17520363.2025.2595911"],"URL":"https:\/\/doi.org\/10.1080\/17520363.2025.2595911","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"type":"print","value":"1752-0363"},{"type":"electronic","value":"1752-0371"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}